Imaging in Gastrointestinal Cancer

作者: Minsig Choi , Anthony F. Shields

DOI: 10.1007/978-3-642-13306-0_1

关键词:

摘要: Routine and innovative imaging approaches are used for screening, diagnosis staging, monitoring treatment, surveillance in gastrointestinal cancers. While screening endoscopy has been the standard diagnosing most tumors, noninvasive CT colonography evolved is beginning to find routine use practice. For scan backbone of over last 30 years. Functional modalities, such as PET scans, now employed an added tool assist staging GI cancers, particularly detect occult metastatic disease so futile surgical interventions can be avoided. adopted esophageal cancers data evolving other Clinical trials using functional early treatment limited. The best cancer, where a multi-institutional study showed that done at 2 weeks after induction chemotherapy could identify patients with metabolic response. Future clinical may enable clinicians provide rapid adjustments therapy each patient. role resected cancer recurrence, which amenable curative resections. Studies have shown follow-up CT, along CEA colonoscopy improve survival colorectal patients. Ultimately, proper all available technology will translate improved outcomes

参考文章(76)
Harufumi Makino, Hisashi Gunji, Kiyohiko Shuto, Shinichi Okazumi, Takayuki Tohma, Hidehiro Kudo, Takenori Ochiai, Akihiro Cho, Katsuhiko Matsubara, Ryoyu Mochiduki, Relationship between glucose transporter, hexokinase and FDG-PET in esophageal cancer. Hepato-gastroenterology. ,vol. 52, pp. 486- 490 ,(2005)
A Dimitrakopoulou-Strauss, L G Strauss, J Rudi, PET-FDG as predictor of therapy response in patients with colorectal carcinoma. The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine. ,vol. 47, pp. 8- 13 ,(2003)
Alvaro Figueredo, , R Bryan Rumble, Jean Maroun, Craig C Earle, Bernard Cummings, Robin McLeod, Lisa Zuraw, Caroline Zwaal, Follow-up of patients with curatively resected colorectal cancer: a practice guideline BMC Cancer. ,vol. 3, pp. 26- 26 ,(2003) , 10.1186/1471-2407-3-26
Nadav Dujovny, Jon S. Hourigan, Colorectal Cancer: Surveillance Springer, New York, NY. pp. 803- 812 ,(2011) , 10.1007/978-1-4419-1584-9_48
Kaichi Isono, Shinichi Okazumi, Kazuo Enomoto, Toshiyuki Kikuchi, Munemasa Ryu, Takehide Asano, Masahiko Ozaki, Haruyuki Hayashi, Hiroshi Yamamoto, Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment. The Journal of Nuclear Medicine. ,vol. 33, pp. 333- 339 ,(1992)
William C. Eckelman, Ronald D. Neumann, Luigi Aloj, Elaine Jagoda, Corradina Caracó, Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture. Cancer Research. ,vol. 59, pp. 4709- 4714 ,(1999)
M Findlay, H Young, D Cunningham, A Iveson, B Cronin, T Hickish, B Pratt, J Husband, M Flower, R Ott, Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil. Journal of Clinical Oncology. ,vol. 14, pp. 700- 708 ,(1996) , 10.1200/JCO.1996.14.3.700
Mark Jeffery, Brigid E Hickey, Phil N Hider, Adrienne M See, Follow-up strategies for patients treated for non-metastatic colorectal cancer Cochrane Database of Systematic Reviews. ,vol. 2016, pp. 1- 27 ,(2016) , 10.1002/14651858.CD002200.PUB3
Jose G Guillem, Harvey G Moore, Timothy Akhurst, David S Klimstra, Leyo Ruo, Madhu Mazumdar, Bruce D Minsky, Leonard Saltz, W Douglas Wong, Steven Larson, Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer1 1No competing interests declared. Journal of the American College of Surgeons. ,vol. 199, pp. 1- 7 ,(2004) , 10.1016/J.JAMCOLLSURG.2004.02.024
Ryunosuke Kanamaru, Tatuo Ido, Kazuo Kubota, Takashi Yoshioka, Gengo Yamaura, Hiroshi Fukuda, Tetsuro Yamazaki, Toshiyuki Saginoya, Hiromu Takahashi, Keiichirou Yamaguchi, Evaluation of 18F-FDG PET in patients with advanced, metastatic, or recurrent gastric cancer. The Journal of Nuclear Medicine. ,vol. 44, pp. 690- 699 ,(2003)